Grifols, S.A. (GIKLY)
OTCMKTS · Delayed Price · Currency is USD
7.49
0.00 (0.00%)
Aug 28, 2025, 8:00 PM EDT
Grifols Market Cap
Grifols has a market cap or net worth of $8.68 billion as of August 29, 2025. Its market cap has increased by 35.86% in one year.
Market Cap
8.68B
Enterprise Value
22.12B
Revenue
8.74B
Ranking
n/a
PE Ratio
24.84
Stock Price
$7.49
Market Cap Chart
Since May 18, 2006, Grifols's market cap has increased from 931.51M to 8.68B, an increase of 831.61%. That is a compound annual growth rate of 12.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 8.57B | 45.71% |
| Dec 31, 2024 | 5.88B | -42.36% |
| Dec 29, 2023 | 10.20B | 45.60% |
| Dec 30, 2022 | 7.01B | -36.73% |
| Dec 30, 2021 | 11.08B | -36.06% |
| Dec 31, 2020 | 17.32B | -17.72% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 832.17M |
| Elite Pharmaceuticals | 734.61M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 655.63M |
| Northwest Biotherapeutics | 448.50M |
| CytoDyn | 376.00M |
| American Oncology Network | 343.87M |